Filing Details
- Accession Number:
- 0001209191-20-002628
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-08 19:35:18
- Reporting Period:
- 2020-01-06
- Accepted Time:
- 2020-01-08 19:35:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1733642 | San Pui Kwan | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Principal Acctg Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-06 | 25,000 | $10.94 | 44,434 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-06 | 7,000 | $14.28 | 51,434 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-06 | 30,000 | $6.08 | 81,434 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-06 | 37,300 | $8.19 | 118,734 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-06 | 23,612 | $3.57 | 142,346 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-06 | 72,956 | $34.39 | 69,390 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-06 | 49,956 | $34.83 | 19,434 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-01-06 | 25,000 | $0.00 | 25,000 | $10.94 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-01-06 | 7,000 | $0.00 | 7,000 | $14.28 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-01-06 | 30,000 | $0.00 | 30,000 | $6.08 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-01-06 | 37,300 | $0.00 | 37,300 | $8.19 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-01-06 | 23,612 | $0.00 | 23,612 | $3.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-12-31 | No | 4 | M | Direct | |
| 0 | 2023-07-23 | No | 4 | M | Direct | |
| 0 | 2024-01-02 | No | 4 | M | Direct | |
| 0 | 2025-02-23 | No | 4 | M | Direct | |
| 16,388 | 2026-03-07 | No | 4 | M | Direct |
Footnotes
- Includes 685 shares acquired under the Issuer's employee stock purchase plan since the last date of the reporting person's last ownership report.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $33.90 to $34.69 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $34.70 to $35.51 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- As of January 6, 2020, and prior to this transaction, the exercised options were fully vested.
- Not applicable.
Billionaire Hedge Funds
